The Patient-Driven Groupings Model (PDGM) has only been in effect for two full months, but it already appears to be making its mark on the home health market, at least anecdotally. The shifts in the market have even caught the attention of S&P Global Ratings, one of the world’s largest providers of independent credit risk research. S&P Global Ratings — a part of S&P Global Inc. (NYSE: SPGI) — analyzed PDGM’s likely impact on the home health market in a report released at the end of February. Among its key takeaways, the report supports the somewhat disputed notion that PDGM may ultimately push 30% of home health businesses out of the $100 billion market. In addition to offering its take on PGDM-fueled consolidation, the report also dug into several indirect consequences that may arise from the Medicare reimbursement overhaul.
Read the full article: Skilled Nursing Facilities, Long-Term Care Hospitals May Look to Cash in on PDGM Turmoil //